LANCET INFECT DIS 润色咨询

LANCET INFECTIOUS DISEASES

出版年份：2001 年文章数：828 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：3.4% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1099522, encodeId=b47510995224e, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099521, encodeId=33ef1099521c8, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897815, encodeId=f08089e81555, content=10.2号提交后with editor了，10.7号Under review, 最新一次日期变动时11.03 ，但是状态一直都是Under review,现在就剩这篇文章掉着口气，希望有好结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=184f2340064, createdName=1228bd54m04(暂无昵称), createdTime=Sun Nov 08 20:52:48 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859541, encodeId=f703859541a5, content=由于新冠特殊，神速，直接录用comment，绝赞！后来还接受2次快速审稿任务。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Fri Apr 17 14:53:02 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583016, encodeId=f1b3583016b0, content=最终结果怎么样？我的投稿40天，还是with editor<span class="quote">136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表:<br>投稿19天，依然with editor，fingers cross</span>, beContent=136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表: 投稿19天，依然with editor，fingers cross, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583017, encodeId=b42f58301e74, content=大神，一直是with editor是怎么回事，难道真的像投稿时邮件所说编辑决定是一个月，若送外审可能两三个月不和作者联系<span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 03:03:00 发表: 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853021, encodeId=e7048530212c, content=审稿速度:12.0<br>经验分享：请问with editor的时间一般多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f85414103, createdName=ms8762254248151793, createdTime=Tue Aug 06 21:46:27 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571810, encodeId=813a5e1810c8, content=牛逼！<span class="quote">likecrazy 2018-07-20 发表::<br>研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span><span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 发表:: 研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17ee2392668, createdName=12338ab2m12暂无昵称, createdTime=Sun Jun 02 00:00:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566972, encodeId=54555669e218, content=投稿19天，依然with editor，fingers cross, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a122550087, createdName=1253de66m17(暂无昵称), createdTime=Tue Feb 19 22:03:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559392, encodeId=8669559392cf, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bc292245, createdName=likecrazy, createdTime=Fri Jul 20 03:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=)]
    2021-12-29 Gym璨烨

    选择期刊时应该注意什么？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1099522, encodeId=b47510995224e, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099521, encodeId=33ef1099521c8, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897815, encodeId=f08089e81555, content=10.2号提交后with editor了，10.7号Under review, 最新一次日期变动时11.03 ，但是状态一直都是Under review,现在就剩这篇文章掉着口气，希望有好结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=184f2340064, createdName=1228bd54m04(暂无昵称), createdTime=Sun Nov 08 20:52:48 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859541, encodeId=f703859541a5, content=由于新冠特殊，神速，直接录用comment，绝赞！后来还接受2次快速审稿任务。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Fri Apr 17 14:53:02 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583016, encodeId=f1b3583016b0, content=最终结果怎么样？我的投稿40天，还是with editor<span class="quote">136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表:<br>投稿19天，依然with editor，fingers cross</span>, beContent=136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表: 投稿19天，依然with editor，fingers cross, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583017, encodeId=b42f58301e74, content=大神，一直是with editor是怎么回事，难道真的像投稿时邮件所说编辑决定是一个月，若送外审可能两三个月不和作者联系<span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 03:03:00 发表: 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853021, encodeId=e7048530212c, content=审稿速度:12.0<br>经验分享：请问with editor的时间一般多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f85414103, createdName=ms8762254248151793, createdTime=Tue Aug 06 21:46:27 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571810, encodeId=813a5e1810c8, content=牛逼！<span class="quote">likecrazy 2018-07-20 发表::<br>研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span><span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 发表:: 研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17ee2392668, createdName=12338ab2m12暂无昵称, createdTime=Sun Jun 02 00:00:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566972, encodeId=54555669e218, content=投稿19天，依然with editor，fingers cross, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a122550087, createdName=1253de66m17(暂无昵称), createdTime=Tue Feb 19 22:03:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559392, encodeId=8669559392cf, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bc292245, createdName=likecrazy, createdTime=Fri Jul 20 03:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=)]
    2021-12-27 msSSSSSD

    选刊的流程是什么？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1099522, encodeId=b47510995224e, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099521, encodeId=33ef1099521c8, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897815, encodeId=f08089e81555, content=10.2号提交后with editor了，10.7号Under review, 最新一次日期变动时11.03 ，但是状态一直都是Under review,现在就剩这篇文章掉着口气，希望有好结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=184f2340064, createdName=1228bd54m04(暂无昵称), createdTime=Sun Nov 08 20:52:48 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859541, encodeId=f703859541a5, content=由于新冠特殊，神速，直接录用comment，绝赞！后来还接受2次快速审稿任务。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Fri Apr 17 14:53:02 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583016, encodeId=f1b3583016b0, content=最终结果怎么样？我的投稿40天，还是with editor<span class="quote">136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表:<br>投稿19天，依然with editor，fingers cross</span>, beContent=136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表: 投稿19天，依然with editor，fingers cross, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583017, encodeId=b42f58301e74, content=大神，一直是with editor是怎么回事，难道真的像投稿时邮件所说编辑决定是一个月，若送外审可能两三个月不和作者联系<span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 03:03:00 发表: 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853021, encodeId=e7048530212c, content=审稿速度:12.0<br>经验分享：请问with editor的时间一般多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f85414103, createdName=ms8762254248151793, createdTime=Tue Aug 06 21:46:27 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571810, encodeId=813a5e1810c8, content=牛逼！<span class="quote">likecrazy 2018-07-20 发表::<br>研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span><span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 发表:: 研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17ee2392668, createdName=12338ab2m12暂无昵称, createdTime=Sun Jun 02 00:00:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566972, encodeId=54555669e218, content=投稿19天，依然with editor，fingers cross, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a122550087, createdName=1253de66m17(暂无昵称), createdTime=Tue Feb 19 22:03:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559392, encodeId=8669559392cf, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bc292245, createdName=likecrazy, createdTime=Fri Jul 20 03:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=)]
    2020-11-08 1228bd54m04(暂无昵称)

    10.2号提交后with editor了，10.7号Under review, 最新一次日期变动时11.03 ，但是状态一直都是Under review,现在就剩这篇文章掉着口气，希望有好结果吧。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1099522, encodeId=b47510995224e, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099521, encodeId=33ef1099521c8, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897815, encodeId=f08089e81555, content=10.2号提交后with editor了，10.7号Under review, 最新一次日期变动时11.03 ，但是状态一直都是Under review,现在就剩这篇文章掉着口气，希望有好结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=184f2340064, createdName=1228bd54m04(暂无昵称), createdTime=Sun Nov 08 20:52:48 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859541, encodeId=f703859541a5, content=由于新冠特殊，神速，直接录用comment，绝赞！后来还接受2次快速审稿任务。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Fri Apr 17 14:53:02 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583016, encodeId=f1b3583016b0, content=最终结果怎么样？我的投稿40天，还是with editor<span class="quote">136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表:<br>投稿19天，依然with editor，fingers cross</span>, beContent=136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表: 投稿19天，依然with editor，fingers cross, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583017, encodeId=b42f58301e74, content=大神，一直是with editor是怎么回事，难道真的像投稿时邮件所说编辑决定是一个月，若送外审可能两三个月不和作者联系<span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 03:03:00 发表: 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853021, encodeId=e7048530212c, content=审稿速度:12.0<br>经验分享：请问with editor的时间一般多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f85414103, createdName=ms8762254248151793, createdTime=Tue Aug 06 21:46:27 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571810, encodeId=813a5e1810c8, content=牛逼！<span class="quote">likecrazy 2018-07-20 发表::<br>研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span><span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 发表:: 研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17ee2392668, createdName=12338ab2m12暂无昵称, createdTime=Sun Jun 02 00:00:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566972, encodeId=54555669e218, content=投稿19天，依然with editor，fingers cross, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a122550087, createdName=1253de66m17(暂无昵称), createdTime=Tue Feb 19 22:03:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559392, encodeId=8669559392cf, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bc292245, createdName=likecrazy, createdTime=Fri Jul 20 03:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=)]
    2020-04-17 ms5891867453131702

    由于新冠特殊，神速，直接录用comment，绝赞！后来还接受2次快速审稿任务。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1099522, encodeId=b47510995224e, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099521, encodeId=33ef1099521c8, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897815, encodeId=f08089e81555, content=10.2号提交后with editor了，10.7号Under review, 最新一次日期变动时11.03 ，但是状态一直都是Under review,现在就剩这篇文章掉着口气，希望有好结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=184f2340064, createdName=1228bd54m04(暂无昵称), createdTime=Sun Nov 08 20:52:48 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859541, encodeId=f703859541a5, content=由于新冠特殊，神速，直接录用comment，绝赞！后来还接受2次快速审稿任务。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Fri Apr 17 14:53:02 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583016, encodeId=f1b3583016b0, content=最终结果怎么样？我的投稿40天，还是with editor<span class="quote">136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表:<br>投稿19天，依然with editor，fingers cross</span>, beContent=136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表: 投稿19天，依然with editor，fingers cross, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583017, encodeId=b42f58301e74, content=大神，一直是with editor是怎么回事，难道真的像投稿时邮件所说编辑决定是一个月，若送外审可能两三个月不和作者联系<span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 03:03:00 发表: 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853021, encodeId=e7048530212c, content=审稿速度:12.0<br>经验分享：请问with editor的时间一般多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f85414103, createdName=ms8762254248151793, createdTime=Tue Aug 06 21:46:27 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571810, encodeId=813a5e1810c8, content=牛逼！<span class="quote">likecrazy 2018-07-20 发表::<br>研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span><span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 发表:: 研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17ee2392668, createdName=12338ab2m12暂无昵称, createdTime=Sun Jun 02 00:00:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566972, encodeId=54555669e218, content=投稿19天，依然with editor，fingers cross, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a122550087, createdName=1253de66m17(暂无昵称), createdTime=Tue Feb 19 22:03:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559392, encodeId=8669559392cf, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bc292245, createdName=likecrazy, createdTime=Fri Jul 20 03:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=)]
    2020-01-10 14689d96m98(暂无昵称)

    最终结果怎么样？我的投稿40天，还是with editor136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表:
    投稿19天，依然with editor，fingers cross

    136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表: 投稿19天，依然with editor，fingers cross

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1099522, encodeId=b47510995224e, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099521, encodeId=33ef1099521c8, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897815, encodeId=f08089e81555, content=10.2号提交后with editor了，10.7号Under review, 最新一次日期变动时11.03 ，但是状态一直都是Under review,现在就剩这篇文章掉着口气，希望有好结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=184f2340064, createdName=1228bd54m04(暂无昵称), createdTime=Sun Nov 08 20:52:48 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859541, encodeId=f703859541a5, content=由于新冠特殊，神速，直接录用comment，绝赞！后来还接受2次快速审稿任务。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Fri Apr 17 14:53:02 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583016, encodeId=f1b3583016b0, content=最终结果怎么样？我的投稿40天，还是with editor<span class="quote">136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表:<br>投稿19天，依然with editor，fingers cross</span>, beContent=136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表: 投稿19天，依然with editor，fingers cross, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583017, encodeId=b42f58301e74, content=大神，一直是with editor是怎么回事，难道真的像投稿时邮件所说编辑决定是一个月，若送外审可能两三个月不和作者联系<span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 03:03:00 发表: 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853021, encodeId=e7048530212c, content=审稿速度:12.0<br>经验分享：请问with editor的时间一般多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f85414103, createdName=ms8762254248151793, createdTime=Tue Aug 06 21:46:27 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571810, encodeId=813a5e1810c8, content=牛逼！<span class="quote">likecrazy 2018-07-20 发表::<br>研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span><span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 发表:: 研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17ee2392668, createdName=12338ab2m12暂无昵称, createdTime=Sun Jun 02 00:00:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566972, encodeId=54555669e218, content=投稿19天，依然with editor，fingers cross, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a122550087, createdName=1253de66m17(暂无昵称), createdTime=Tue Feb 19 22:03:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559392, encodeId=8669559392cf, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bc292245, createdName=likecrazy, createdTime=Fri Jul 20 03:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=)]
    2020-01-10 14689d96m98(暂无昵称)

    大神，一直是with editor是怎么回事，难道真的像投稿时邮件所说编辑决定是一个月，若送外审可能两三个月不和作者联系likecrazy 2018-07-20 03:03:00 发表:
    有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献

    likecrazy 2018-07-20 03:03:00 发表: 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1099522, encodeId=b47510995224e, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099521, encodeId=33ef1099521c8, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897815, encodeId=f08089e81555, content=10.2号提交后with editor了，10.7号Under review, 最新一次日期变动时11.03 ，但是状态一直都是Under review,现在就剩这篇文章掉着口气，希望有好结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=184f2340064, createdName=1228bd54m04(暂无昵称), createdTime=Sun Nov 08 20:52:48 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859541, encodeId=f703859541a5, content=由于新冠特殊，神速，直接录用comment，绝赞！后来还接受2次快速审稿任务。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Fri Apr 17 14:53:02 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583016, encodeId=f1b3583016b0, content=最终结果怎么样？我的投稿40天，还是with editor<span class="quote">136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表:<br>投稿19天，依然with editor，fingers cross</span>, beContent=136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表: 投稿19天，依然with editor，fingers cross, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583017, encodeId=b42f58301e74, content=大神，一直是with editor是怎么回事，难道真的像投稿时邮件所说编辑决定是一个月，若送外审可能两三个月不和作者联系<span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 03:03:00 发表: 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853021, encodeId=e7048530212c, content=审稿速度:12.0<br>经验分享：请问with editor的时间一般多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f85414103, createdName=ms8762254248151793, createdTime=Tue Aug 06 21:46:27 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571810, encodeId=813a5e1810c8, content=牛逼！<span class="quote">likecrazy 2018-07-20 发表::<br>研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span><span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 发表:: 研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17ee2392668, createdName=12338ab2m12暂无昵称, createdTime=Sun Jun 02 00:00:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566972, encodeId=54555669e218, content=投稿19天，依然with editor，fingers cross, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a122550087, createdName=1253de66m17(暂无昵称), createdTime=Tue Feb 19 22:03:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559392, encodeId=8669559392cf, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bc292245, createdName=likecrazy, createdTime=Fri Jul 20 03:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=)]
    2019-08-06 ms8762254248151793

    审稿速度:12.0
    经验分享：请问with editor的时间一般多久？

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1099522, encodeId=b47510995224e, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099521, encodeId=33ef1099521c8, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897815, encodeId=f08089e81555, content=10.2号提交后with editor了，10.7号Under review, 最新一次日期变动时11.03 ，但是状态一直都是Under review,现在就剩这篇文章掉着口气，希望有好结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=184f2340064, createdName=1228bd54m04(暂无昵称), createdTime=Sun Nov 08 20:52:48 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859541, encodeId=f703859541a5, content=由于新冠特殊，神速，直接录用comment，绝赞！后来还接受2次快速审稿任务。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Fri Apr 17 14:53:02 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583016, encodeId=f1b3583016b0, content=最终结果怎么样？我的投稿40天，还是with editor<span class="quote">136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表:<br>投稿19天，依然with editor，fingers cross</span>, beContent=136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表: 投稿19天，依然with editor，fingers cross, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583017, encodeId=b42f58301e74, content=大神，一直是with editor是怎么回事，难道真的像投稿时邮件所说编辑决定是一个月，若送外审可能两三个月不和作者联系<span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 03:03:00 发表: 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853021, encodeId=e7048530212c, content=审稿速度:12.0<br>经验分享：请问with editor的时间一般多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f85414103, createdName=ms8762254248151793, createdTime=Tue Aug 06 21:46:27 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571810, encodeId=813a5e1810c8, content=牛逼！<span class="quote">likecrazy 2018-07-20 发表::<br>研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span><span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 发表:: 研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17ee2392668, createdName=12338ab2m12暂无昵称, createdTime=Sun Jun 02 00:00:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566972, encodeId=54555669e218, content=投稿19天，依然with editor，fingers cross, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a122550087, createdName=1253de66m17(暂无昵称), createdTime=Tue Feb 19 22:03:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559392, encodeId=8669559392cf, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bc292245, createdName=likecrazy, createdTime=Fri Jul 20 03:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=)]
    2019-06-02 12338ab2m12暂无昵称

    牛逼！likecrazy 2018-07-20 发表::
    研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献    likecrazy 2018-07-20 03:03:00 发表:
    有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献

    likecrazy 2018-07-20 发表:: 研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1099522, encodeId=b47510995224e, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099521, encodeId=33ef1099521c8, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897815, encodeId=f08089e81555, content=10.2号提交后with editor了，10.7号Under review, 最新一次日期变动时11.03 ，但是状态一直都是Under review,现在就剩这篇文章掉着口气，希望有好结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=184f2340064, createdName=1228bd54m04(暂无昵称), createdTime=Sun Nov 08 20:52:48 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859541, encodeId=f703859541a5, content=由于新冠特殊，神速，直接录用comment，绝赞！后来还接受2次快速审稿任务。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Fri Apr 17 14:53:02 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583016, encodeId=f1b3583016b0, content=最终结果怎么样？我的投稿40天，还是with editor<span class="quote">136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表:<br>投稿19天，依然with editor，fingers cross</span>, beContent=136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表: 投稿19天，依然with editor，fingers cross, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583017, encodeId=b42f58301e74, content=大神，一直是with editor是怎么回事，难道真的像投稿时邮件所说编辑决定是一个月，若送外审可能两三个月不和作者联系<span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 03:03:00 发表: 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853021, encodeId=e7048530212c, content=审稿速度:12.0<br>经验分享：请问with editor的时间一般多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f85414103, createdName=ms8762254248151793, createdTime=Tue Aug 06 21:46:27 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571810, encodeId=813a5e1810c8, content=牛逼！<span class="quote">likecrazy 2018-07-20 发表::<br>研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span><span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 发表:: 研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17ee2392668, createdName=12338ab2m12暂无昵称, createdTime=Sun Jun 02 00:00:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566972, encodeId=54555669e218, content=投稿19天，依然with editor，fingers cross, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a122550087, createdName=1253de66m17(暂无昵称), createdTime=Tue Feb 19 22:03:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559392, encodeId=8669559392cf, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bc292245, createdName=likecrazy, createdTime=Fri Jul 20 03:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=)]
    2019-02-19 1253de66m17(暂无昵称)

    投稿19天，依然with editor，fingers cross

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1099522, encodeId=b47510995224e, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099521, encodeId=33ef1099521c8, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897815, encodeId=f08089e81555, content=10.2号提交后with editor了，10.7号Under review, 最新一次日期变动时11.03 ，但是状态一直都是Under review,现在就剩这篇文章掉着口气，希望有好结果吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=184f2340064, createdName=1228bd54m04(暂无昵称), createdTime=Sun Nov 08 20:52:48 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859541, encodeId=f703859541a5, content=由于新冠特殊，神速，直接录用comment，绝赞！后来还接受2次快速审稿任务。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Fri Apr 17 14:53:02 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583016, encodeId=f1b3583016b0, content=最终结果怎么样？我的投稿40天，还是with editor<span class="quote">136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表:<br>投稿19天，依然with editor，fingers cross</span>, beContent=136oM9N0017(暂无昵称) 2019-02-19 22:03:00 发表: 投稿19天，依然with editor，fingers cross, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583017, encodeId=b42f58301e74, content=大神，一直是with editor是怎么回事，难道真的像投稿时邮件所说编辑决定是一个月，若送外审可能两三个月不和作者联系<span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 03:03:00 发表: 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9aa65146705, createdName=14689d96m98(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853021, encodeId=e7048530212c, content=审稿速度:12.0<br>经验分享：请问with editor的时间一般多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66f85414103, createdName=ms8762254248151793, createdTime=Tue Aug 06 21:46:27 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571810, encodeId=813a5e1810c8, content=牛逼！<span class="quote">likecrazy 2018-07-20 发表::<br>研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span><span class="quote">likecrazy 2018-07-20 03:03:00 发表:<br>有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献</span>, beContent=likecrazy 2018-07-20 发表:: 研究方向：传染病学;细菌耐药; 接收率：约5% 审稿时间：约2个月 SCI(2016)：19 有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17ee2392668, createdName=12338ab2m12暂无昵称, createdTime=Sun Jun 02 00:00:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566972, encodeId=54555669e218, content=投稿19天，依然with editor，fingers cross, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a122550087, createdName=1253de66m17(暂无昵称), createdTime=Tue Feb 19 22:03:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559392, encodeId=8669559392cf, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bc292245, createdName=likecrazy, createdTime=Fri Jul 20 03:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=)]
    2018-07-20 likecrazy

    审稿速度:2.0 | 投稿命中率:5.0
    经验分享：有幸中过两篇，都是偏交叉学科，同时抓住热点问题研究，近几年的Ebola 和Zika 相关文章的高引用肯定是为分数提高做了很多贡献

    0

共16条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分